DiaMed Q.C. System 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Bio-Rad 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2017-09-07
  • 사례 출판 날짜
    2017-09-07
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: bio-rad diamed q.C. system medical device manufacturer, bio-rad, has issued a safety alert concerning its diamed q.C. system. the affected devices are identified as the following:- material number: 45950 lot number ihd: i) 45950 46 1 and ii) 45950 47 1 lot number sap: i) 166035461 and ii) 172383471 expiry date: i) 25 sep 2017 and ii) 9 oct 2017 the manufacturer has been made aware that samples of the product diamed q.C. system, ihd lot number 45950 46 1 and 45950 47 1, show excessive hemolysis in samples 1 and 4, and weakly in sample 2. tests have been performed internally and the manufacturer can confirm that currently a clear result is returned with manual testing and on the saxo- swing, ih-1000 with the hemolysed qc samples. with ih-500, users may observe uninterpretable results on reverse grouping. in this case, users should use another sample to perform the reverse grouping. [note: tests involving serum 1 and serum 2 are in no way affected.] according to the manufacturer, a risk assessment has been performed and no patient risk has been identified. users may continue to use the hemolysed cells as long as they give the expected results. the current situation has shown that the hemolysed lots will still allow the customers to perform qc testing for the following applications: typing abo/d and phenotype rh kell antibody screening and identification compatibility testing according to the local supplier, the affected products are not distributed in hong kong if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 7 september 2017.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Bio-Rad DiaMed Q.C. System
  • Manufacturer

Manufacturer